# FDA 483 - DCI Donor Services Tissue Bank - August 28, 2025

Source: https://www.keypedia.com/records/483/dci-donor-services-tissue-bank/db8007ca-e6e8-40c4-b8b1-915159d4f902

> FDA 483 for DCI Donor Services Tissue Bank on August 28, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: DCI Donor Services Tissue Bank
- Inspection Date: 2025-08-28
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of DCI Donor Services, Inc. in Nashville, TN, a human tissue processor, revealed three significant observations. The firm failed to properly determine donor eligibility for individuals with communicable disease risk factors, maintained facilities in a poor state of repair with chipping paint in cleanrooms, and did not clean manufacturing equipment according to established schedules, leading to visible tissue residue. These issues raise concerns about the quality and safety of processed musculoskeletal tissues.

## Related Officers

- [Jannet M. Peroti](https://www.keypedia.com/people/jannet-m-peroti/204a2444-ae5c-42dc-b4a3-f2024db3368e)
- [Fabian N. Chaparro-rodriguez](https://www.keypedia.com/people/fabian-n-chaparro-rodriguez/f14fd931-0830-4a84-a287-2dd85e40195d)
- [Christopher J. Adams](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/dci-donor-services-tissue-bank/10515d53-230a-47a1-b371-1bfd58d5ca8a

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea